ENTITY
Torrent Pharmaceuticals

Torrent Pharmaceuticals (TRP IN)

100
Analysis
Health CareIndia
Torrent Pharmaceuticals Ltd. manufactures bulk drugs and pharmaceutical formulations. The Company's formulations include cardio-vascular, psychotropic and anti-biotic drugs while its bulk drugs include atenolol, ciprofloxacin and norfloxacin. Torrent Pharmaceuticals has wholly owned subsidiaries in several regulated and less regulated international markets.
more
Refresh
27 Nov 2018 05:23

EM Health Care:  Late Cycle Rotation

Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...

Logo
336 Views
Share
17 Nov 2018 13:46

Eris Lifesciences - 2QFY19 – Acquisitions Drive Top Line Much Higher, Bottom Line to Follow by FY20E

Eris Lifesciences (ERIS IN) reported lower than expected performance in 2QFY19.  Revenues were 5% lower than our estimates at Rs 2,642 mn. The...

Logo
407 Views
Share
12 Oct 2018 09:26

Glenmark Pharmaceuticals: Attempt Out of Generic

We initiate our coverage on Glenmark Pharmaceuticals (GNP IN) (“Glenmark”)’s GNPIN 4.5% 8/21s (BB-/BB by S&P and Fitch, respectively) with a...

Logo
422 Views
Share
22 Dec 2017 12:34

Reliance Infra Sells Mumbai Electricity Business at a Good Price, But Upside Already in Price Now

Reliance Infrastructure Ltd (RELI IN) finds a buyer for its Mumbai businessReliance Infrastructure Ltd (RELI IN) yesterday announced signing of...

Logo
202 Views
Share
03 Oct 2017 10:33

Multiple Buyers for Reliance Infra's Mumbai Electricity Business - Attractiveness of Low Risk Assets

Reliance Infrastructure is selling its Mumbai Electricity Business to Greenko?As per news reports, Greenko (in a consortium with GIC of Singapore...

Logo
191 Views
Share
x